Wolverine Asset Management’s Immunomedics Inc IMMU Stock Holding History

Wolverine Asset Management’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-13,600	Closed	-$194K	–	1822
2018 Q4	$194K	Hold	13,600	–	–	﹤0.01%	1249
2018 Q3	$283K	Hold	13,600	–	–	﹤0.01%	1141
2018 Q2	$321K	Buy	+13,600	New	+$273K	﹤0.01%	1028
2018 Q1	–	Sell	-6,100	Closed	-$98K	–	1783
2017 Q4	$98K	Buy	+6,100	New	+$72K	﹤0.01%	1185
2017 Q3	–	Sell	-2,000	Closed	-$17K	–	1549
2017 Q2	$17K	Sell	2,000 -8,000	-80%	-$56.2K	﹤0.01%	1197
2017 Q1	$64K	Hold	10,000	–	–	﹤0.01%	996
2016 Q4	$36K	Buy	+10,000	New	+$29.6K	﹤0.01%	1046
2013 Q4	–	Sell	-12	Closed	-$2K	–	3005
2013 Q3	$2K	Hold	12	–	–	﹤0.01%	2548
2013 Q2	$2K	Buy	+12	New	+$39	﹤0.01%	2519

Wolverine Asset Management's IMMU Position: Q4 2020 in Review

Wolverine Asset Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 59,991 shares — an estimated $5.1M sold.

Wolverine Asset Management first reported a position in IMMU in Q2 2013 and held it in 10 quarters. The position peaked at $5.74M in Q3 2017. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Wolverine Asset Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Wolverine Asset Management sold 59,991 Immunomedics Inc shares in Q4 2020, an estimated $5.1M.
Wolverine Asset Management first reported a position in Immunomedics Inc in Q2 2013 and held it in 10 quarters.
Wolverine Asset Management's Immunomedics Inc position peaked at $5.74M in Q3 2017.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Wolverine Asset Management's 13F filing for Q4 2020, filed 12 Feb 2021.